News
Switzerland To Get A $518mn Fill-Finish Plant From Lonza
Lonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According to the firm, the...
News
Pfizer And Touchlight Enter Into A Patent Licence Agreement
Pfizer and another pharmaceutical major, Touchlight, have come to a deal on a significant non-exclusive patent licence. Touchlight is a firm that focuses on...
News
AstraZeneca, GSK Overcame Q2 Issues While Roche Stocks Fell
The standard response to any poor performance is to blame the supply chain, which has almost attained the status of a joke. However, it...
News
FDA Allows Licenced Pharmacists To Sell Paxlovid From Pfizer
On July 6, the US Food and Drug Administration modified the COVID-19 antiviral drug Paxlovid's emergency use authorization to permit state-licensed pharmacists to recommend the...
News
Deloitte Latest Survey – Mature R&D Yields Enterprise Value
According to the third Real-World Evidence (RWE) benchmarking survey published in June 2022 by Deloitte, there is a segmentation of outcomes between businesses with...
News
Sanofi Starts Fund For The Concerned In Low-Income Nations
The Paris-based pharmaceutical company is setting up a fund to assist companies who want to provide healthcare solutions in neglected areas. The objective is...
News
Novel Ovarian Cancer Treatment By GSK Approved In Singapore
The oral, once-daily Zejula (niraparib) tablet, a first-line and recurrent upkeep care for women with advanced epithelial high-grade ovarian, fallopian tube, or primary peritoneal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read